Clinical trial
Lamotrigine in Treatment Resistant Depression in Adolescents
NCT00284791 · MaineHealth, Other · Terminated
Key facts
| NCT number | NCT00284791 |
|---|---|
| Title | Lamotrigine in Treatment Resistant Depression in Adolescents |
| Official title | Lamotrigine Use in Treatment Refractory Depression in Adolescents |
| Lead sponsor | MaineHealth, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Adolescent Depression |
| Intervention type | Drug |
| Interventions | Lamotrigine (drug), Fluoxetine (drug), sertraline (drug) |
| Enrollment | 50 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Feb 1, 2006 |
| Last update posted | May 17, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: